Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda JD Makuza, S Nsanzimana, MA Muhimpundu, LE Pace, J Ntaganira, ... Pan African Medical Journal 22 (1), 2015 | 149 | 2015 |
Concurrent initiation of hepatitis C and opioid use disorder treatment in people who inject drugs ES Rosenthal, R Silk, P Mathur, C Gross, R Eyasu, L Nussdorf, K Hill, ... Clinical Infectious Diseases 71 (7), 1715-1722, 2020 | 97 | 2020 |
Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immuodeficiency virus type 1 Tat HG Guo, S Pati, M Sadowska, M Charurat, M Reitz Journal of virology 78 (17), 9336-9342, 2004 | 89 | 2004 |
Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens A DeVico, T Fouts, GK Lewis, RC Gallo, K Godfrey, M Charurat, I Harris, ... Proceedings of the National Academy of Sciences 104 (44), 17477-17482, 2007 | 85 | 2007 |
Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians O Aina, J Dadik, M Charurat, P Amangaman, S Gurumdi, E Mang, R Guyit, ... Clinical and Vaccine Immunology 12 (4), 525-530, 2005 | 84 | 2005 |
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors MM Sajadi, NT Constantine, DL Mann, M Charurat, E Dadzan, P Kadlecik, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 50 (4), 403-408, 2009 | 81 | 2009 |
Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries M Etienne, M Hossain, R Redfield, K Stafford, A Amoroso Journal of the International Association of Physicians in AIDS Care 9 (2 …, 2010 | 76 | 2010 |
Effectiveness of protease inhibitor/nucleos (t) ide reverse transcriptase inhibitor–based second-line antiretroviral therapy for the treatment of human immunodeficiency virus … AJ Stockdale, MJ Saunders, MA Boyd, LJ Bonnett, V Johnston, ... Clinical infectious diseases 66 (12), 1846-1857, 2018 | 75 | 2018 |
Hepatitis B virus and HIV co-infection among pregnant women in Rwanda M Mutagoma, H Balisanga, SS Malamba, D Sebuhoro, E Remera, ... BMC infectious diseases 17, 1-7, 2017 | 71 | 2017 |
Hepatitis C virus and HIV co-infection among pregnant women in Rwanda M Mutagoma, H Balisanga, D Sebuhoro, A Mbituyumuremyi, E Remera, ... BMC infectious diseases 17 (1), 2017 | 71 | 2017 |
Cervical cancer screening using visual inspection with acetic acid: operational experiences from Ghana and Thailand H Sanghvi, KK Limpaphayom, M Plotkin, E Charurat, A Kleine, E Lu, ... Reproductive health matters 16 (32), 67-77, 2008 | 68 | 2008 |
Syphilis and HIV prevalence and associated factors to their co-infection, hepatitis B and hepatitis C viruses prevalence among female sex workers in Rwanda M Mutagoma, L Nyirazinyoye, D Sebuhoro, DJ Riedel, J Ntaganira BMC infectious diseases 17, 1-9, 2017 | 67 | 2017 |
The impact of mentor mother programs on PMTCT service uptake and retention-in-care at primary health care facilities in Nigeria: a prospective cohort study (MoMent Nigeria) NA Sam-Agudu, LJ Cornelius, JN Okundaye, OA Adeyemi, HO Isah, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 67, S132-S138, 2014 | 62 | 2014 |
Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda JD Makuza, JOT Rwema, CK Ntihabose, D Dushimiyimana, J Umutesi, ... BMC infectious diseases 19, 1-10, 2019 | 61 | 2019 |
Cell phone-based and internet-based monitoring and evaluation of the National Antiretroviral Treatment Program during rapid scale-up in Rwanda: TRACnet, 2004–2010 S Nsanzimana, H Ruton, DW Lowrance, S Cishahayo, JP Nyemazi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (2), e17-e23, 2012 | 60 | 2012 |
Prevalence of anal high-risk human papillomavirus infections among HIV-positive and HIV-negative men who have sex with men in Nigeria RG Nowak, PE Gravitt, X He, S Ketende, W Dauda, H Omuh, WA Blattner, ... Sexually transmitted diseases 43 (4), 243-248, 2016 | 56 | 2016 |
The prevalence of intimate partner violence, associated risk factors, and other moderating effects: findings from the Kenya National Health Demographic Survey P Memiah, T Ah Mu, K Prevot, CK Cook, MM Mwangi, EW Mwangi, ... Journal of interpersonal violence 36 (11-12), 5297-5317, 2021 | 55 | 2021 |
Evaluation of the clinical outcomes of the Test and Treat strategy to implement Treat All in Nigeria: Results from the Nigeria Multi-Center ART Study KA Stafford, SF Odafe, J Lo, R Ibrahim, A Ehoche, M Niyang, GG Aliyu, ... PloS one 14 (7), e0218555, 2019 | 54 | 2019 |
Individual and sexual network predictors of HIV incidence among men who have sex with men in Nigeria RG Nowak, A Mitchell, TA Crowell, H Liu, S Ketende, HO Ramadhani, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (4), 444-453, 2019 | 54 | 2019 |
Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda JA Ndahimana, DJ Riedel, M Mwumvaneza, D Sebuhoro, JC Uwimbabazi, ... Tropical Medicine & International Health 21 (7), 928-935, 2016 | 53 | 2016 |